Skyhawk is committed to discovering, developing and commercializing small molecule therapeutics that correct RNA splicing (e.g. Evrysdi). We work on some of the world’s most intractable diseases including cancer, neurological conditions, and other t…

ConcR’s mission is to predict if a cancer therapy will work, and how. We are developing custom modelling frameworks in collaboration with astrophysicists from Durham, to enable us to model a broader range of the tumour biology than is currently poss…

Skyhawk Therapeutics seeks a Data+DevOps Engineer to join our growing Platform team in Boston, MA. Skyhawk is committed to discovering, developing and commercializing small molecule therapeutics that correct RNA splicing. We use our novel SkySTAR pl…

Symmetry Investments is a post startup c. USD 6.5 billion alternative asset management company with around 220 people across multiple time zones and locations. Our core technology team has been remote first for some time, and the whole company is fo…

Symmetry Investments is a post startup c. 5bn alternative asset management company with around 175 people across multiple time zones and locations. Our core technology team has been remote first for some time, and the whole company is following suit…

ConcR’s mission is to predict if a cancer therapy will work, and how. We are developing custom modelling frameworks in collaboration with astrophysicists from Durham, to enable us to model a broader range of the tumour biology than is currently poss…